CIT v. Glaxo Smithkline Asia (P.) Ltd.
195 Taxmann 35Supreme Court of India2010#2538 most cited
What is CIT v. Glaxo Smithkline Asia (P.) Ltd. authority for?
The Supreme Court may dismiss an appeal challenging the allocation of intra-group cross-charges if the entire transaction is found to be revenue neutral for the relevant assessment year.
46
judgments rely on this decision, according to BharatTax’s citation analysis of 292,668 Indian tax judgments — from 2015 to 2025.
Also referred to as
CIT v. Glaxo Smithkline Asia (P.) Ltd. · revenue neutral transaction · intra-group cross charges · arm's length principle · transfer pricing · Section 92C · Section 92CA · Section 40A(2)(b) · market value · dismissal of Special Leave Petition · inter-company transactions
Also reported as
236 CTR 113
Sections most often in play
Issues it is cited on
Judgments citing CIT v. Glaxo Smithkline Asia (P.) Ltd.
Showing 1–20 of 46 · Page 1 of 3